Autopsy report · NCT03754244

A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“The enrolment task cannot be gotten within the planned time.It mainly includes patients with non-small cell lung cancer failed in standard treatment,with a short survival period.It is hard to obtain observational endpoints for bone-related events.”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 10 months before it started.
Ran for about 1 year 5 months before it stopped.
1 participant enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Sponsor type: Industry
Conditions: Non-small Cell Lung Cancer
Interventions: TQB3456
Participants: 1
Sites: 1
Countries: China

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.